ABOS

Acumen Pharmaceuticals (ABOS)

About Acumen Pharmaceuticals (ABOS)

Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.

Details

Daily high

$1.81

Daily low

$1.58

Price at open

$1.65

52 Week High

$5.09

52 Week Low

$1.53

Market cap

105.1M

Dividend yield

0.00%

Volume

589,692

Avg. volume

383,724

P/E ratio

-1.28

Acumen Pharmaceuticals News